Clinical Trial Update: NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma [Phase 2]

View source ↗

Summary

Updates from a Phase 2 trial evaluating NOX-A12 in combination with bortezomib and dexamethasone in relapsed multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• NOX-A12

Snippet

Sponsor: TME Pharma AG | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED